ArticleBreast cancer research and treatment2014

Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy.

Daniel L Hertz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.